Actively Recruiting
National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
Led by King Saud University · Updated on 2021-09-01
1000
Participants Needed
1
Research Sites
1558 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.
CONDITIONS
Official Title
National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged greater than 18 years old
- Patients must meet one of the following SLE classification criteria: ACR, SLICC, or ACR/EULAR
- No restriction on time since SLE diagnosis
You will not qualify if you...
- Patients who do not meet the specified SLE classification criteria (ACR, SLICC, or ACR/EULAR)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
king Saud University medical city
Riyadh, Central Province, Saudi Arabia, 61961
Actively Recruiting
Research Team
I
Ibrahim Almaghlouth, MSc(c), AmBIM, FRCPC, FACR
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here